UB Paderborn / Katalog / Suche / in CDI

Do Medical Homes Reduce Disparities in Receipt of Preventive Services Between Children Living in Immigrant and Non-immigrant Families?

Journal of immigrant and minority health, 2012-08, Vol.14 (4), p.617-625

2012

Volltextzugriff (PDF)

1805P Efficacy of olaparib (ola) + abiraterone (abi) vs placebo (pbo) + abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial

Annals of oncology, 2023-10, Vol.34, p.S975-S976

2023

Volltextzugriff (PDF)

PROpel: Efficacy of abiraterone + olaparib vs. abiraterone + placebo in the first-line treatment of patients with asymptomatic/mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) at baseline

European urology, 2023-02, Vol.83, p.S1674-S1675

2023

Volltextzugriff (PDF)

A1160 - PROpel: Efficacy of abiraterone + olaparib vs. abiraterone + placebo in the first-line treatment of patients with asymptomatic/mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) at baseline

European urology, 2023-02, Vol.83, p.S1674-S1675

2023

Volltextzugriff (PDF)

Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

Value in health, 2018-05, Vol.21, p.S12

2018

Volltextzugriff (PDF)

PP3 - Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

Value in health, 2018-05, Vol.21, p.S12-S12

2018

Volltextzugriff (PDF)

UNDERSTANDING THE SYMPTOMS, IMPACTS, AND TREATMENT SIDE-EFFECTS OF ADVANCED BLADDER CANCER FROM THE PERSPECTIVE OF THE LITERATURE, CLINICIANS, AND PATIENTS

Value in health, 2017-05, Vol.20 (5), p.A121

2017

Volltextzugriff (PDF)

Comparing the Oncology Pro Label Claims for Europe and The United States: What is the Evidence?

Value in health, 2016-05, Vol.19 (3), p.A159-A159

2016

Volltextzugriff (PDF)

PCN143 - Comparing the Oncology Pro Label Claims for Europe and The United States: What is the Evidence?

Value in health, 2016-05, Vol.19 (3), p.A159-A159

2016

Volltextzugriff (PDF)

QUALITATIVE INTERVIEWS TO UNDERSTAND THE PATIENT EXPERIENCE OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AND EXPLORE THE CONTENT OF PATIENT REPORTED OUTCOME MEASURES

Value in health, 2017-05, Vol.20 (5), p.A120

2017

Volltextzugriff (PDF)

OlympiAD: Health-related quality of life (HRQoL) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice (TPC)

Annals of oncology, 2017-09, Vol.28, p.v96-v96

2017

Volltextzugriff (PDF)

A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

Value in health, 2017-10, Vol.20 (9), p.A454

2017

Volltextzugriff (PDF)

PCN232 - A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

Value in health, 2017-10, Vol.20 (9), p.A454-A454

2017

Volltextzugriff (PDF)

Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities

Clinical, cosmetic and investigational dermatology, 2015-01, Vol.8 (default), p.231-238

2015

Volltextzugriff (PDF)

Estimating the cost of healthcare delivery in three hospitals in southern ghana

Ghana medical journal, 2010-09, Vol.44 (3), p.83-92

2010

Volltextzugriff (PDF)

Oxalose: Refus de diagnostic ante natal traitement conservateur precoce

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 1999, Vol.6, p.S577-S577

1999

Volltextzugriff (PDF)

Molybdenum and phosphorus limitation of moss-associated nitrogen fixation in boreal ecosystems

The New phytologist, 2017-04, Vol.214 (1), p.97-107

2017

Volltextzugriff (PDF)

An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective

Globalization and health, 2009-09, Vol.5 (1), p.10-10, Article 10

2009

Volltextzugriff (PDF)

Pre-rheumatoid arthritis and ACPA: Contribution of ACPAs in the pathogeny of pre-disease stage

Joint, bone, spine : revue du rhumatisme, 2021-05, Vol.88 (3), p.105098-105098, Article 105098

Degboé, Yannick

2021

Volltextzugriff (PDF)

Consequence of vertebral fracture cascades: about a cohort of 79 patients

Osteoporosis international, 2020-12, Vol.31 (12), p.2497-2498

2020

Volltextzugriff (PDF)

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case–control study

Rheumatology international, 2023-02, Vol.43 (2), p.363-366

2023

Volltextzugriff (PDF)

Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature

Osteoporosis international, 2017-11, Vol.28 (11), p.3135-3142

2017

Volltextzugriff (PDF)

Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial

The lancet oncology, 2022-10, Vol.23 (10), p.1297-1307

2022

Volltextzugriff (PDF)

Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients

Supportive care in cancer, 2019-11, Vol.27 (11), p.4189-4198

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Do Medical Homes Reduce Disparities in Receipt of Preventive Services Between Children Living in Immigrant and Non-immigrant Families?

1805P Efficacy of olaparib (ola) + abiraterone (abi) vs placebo (pbo) + abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial

PROpel: Efficacy of abiraterone + olaparib vs. abiraterone + placebo in the first-line treatment of patients with asymptomatic/mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) at baseline

A1160 - PROpel: Efficacy of abiraterone + olaparib vs. abiraterone + placebo in the first-line treatment of patients with asymptomatic/mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC) at baseline

Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

PP3 - Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

UNDERSTANDING THE SYMPTOMS, IMPACTS, AND TREATMENT SIDE-EFFECTS OF ADVANCED BLADDER CANCER FROM THE PERSPECTIVE OF THE LITERATURE, CLINICIANS, AND PATIENTS

Comparing the Oncology Pro Label Claims for Europe and The United States: What is the Evidence?

PCN143 - Comparing the Oncology Pro Label Claims for Europe and The United States: What is the Evidence?

QUALITATIVE INTERVIEWS TO UNDERSTAND THE PATIENT EXPERIENCE OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AND EXPLORE THE CONTENT OF PATIENT REPORTED OUTCOME MEASURES

OlympiAD: Health-related quality of life (HRQoL) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice (TPC)

A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

PCN232 - A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities

Estimating the cost of healthcare delivery in three hospitals in southern ghana

Oxalose: Refus de diagnostic ante natal traitement conservateur precoce

Molybdenum and phosphorus limitation of moss-associated nitrogen fixation in boreal ecosystems

An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective

Pre-rheumatoid arthritis and ACPA: Contribution of ACPAs in the pathogeny of pre-disease stage

Consequence of vertebral fracture cascades: about a cohort of 79 patients

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case–control study

Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature

Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial

Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial

Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients

Suchergebnisse filtern